Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...
Co released the endometrial biopsy findings from its three and six month studies of Proellex(TM) in the treatment of uterine fibroids and endometriosis respectively. The clinical study results of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback